Provided is a cardiovascular disease risk analysis system and method considering sleep apnea factors to analyze a cardiovascular disease risk of sleep apnea patients.

A thrombectomy system incorporates analytical instrumentation to determine the aspirate characteristic (the fluid contents of the thrombectomy catheter) and subsequently selects a thrombectomy operating mode appropriate to the current aspirate characteristic. Aspirate characteristics include: (1) blood, which is slowly aspirated, (2) thrombus which is rapidly aspirated to waste, (3) clot, which is systematically aspirated and (4) clog, which is systematically cleared. A differential viscometer is disclosed for a broad array of applications including thrombectomy, as well as industrial, automotive, environmental and scientific. A variable aperture catheter is disclosed which permits selective aspiration and infusion in either the axial or radial directions.

The approach presented here relates to a determination appliance (100) for determining a viscosity of a fluid. The determination appliance (100) has at least one determination device (110) and a provisioning device (115). The determination device (110) is designed to determine the viscosity of the fluid and/or a rotational speed (ω) of a blade wheel (205) for conveying the fluid by using at least one detected volume flow of the fluid and a detected pressure difference of the fluid. The provisioning device (115) is designed to provide or send a viscosity signal (130) representing the viscosity determined by the determination device (110).

An electronic device includes a sensor capable of detecting pulsation in a target region of a subject; a housing including, at least in part, the sensor; a support portion that supports the housing on a side thereof; an elastic member interposed between the housing and the support portion; and a base portion that allows the support portion to stand upright.

An electronic device according to one aspect includes a blood flow data acquisition unit configured to acquire information related to blood flowing inside a living body as blood flow data based on Doppler shift, a power spectrum calculator configured to calculate a power spectrum of the blood flow data based on the blood flow data, and an outline index calculator configured to calculate an outline index from the power spectrum. An electronic device according to one aspect further includes an estimator configured to estimate viscosity of the blood based on the outline index, and the estimator is configured to display an estimation result of the viscosity of the blood on a display.

The present application discloses a pulse simulator. The pulse simulator includes a pulse simulation assembly configured to receive a pulse simulation signal and simulate a pulse of a living body based on the pulse simulation signal. The pulse simulation assembly includes a mounting plate; a plurality of retractable bolts on the mounting plate; and a plurality of drivers coupled to the plurality of retractable bolts. Each of the plurality of retractable bolts has a first end attached to the mounting plate and a second end opposite to the first end. Each of the plurality of drivers is configured to drive one of the plurality of retractable bolts to retract and extend between a first position and a second position thereby adjusting a distance between a simulated skin portion and the mounting plate in a region corresponding to the one of the plurality of retractable bolts.

A method and system are presented for use in assessment of at least one cardiac parameter of an individual. An electrodes arrangement is applied to an individual's body, for applying an electrical field to the body and providing an electrical output indicative of a systolic impedance change and of a velocity of said change during a cardiac cycle. Also provided is additional data indicative of at least of the following conditions of the individual: a value of total peripheral resistance (TPR), a value of cardiac index (CI), and existence of the AHF condition. Data corresponding to these condition is analyzed to determine whether the TPR satisfies a first predetermined condition and/or the CI satisfies a predetermined second condition and/or whether the acute heart failure (AHF) condition is identified, to thereby use the data indicative of the measured electrical output and selectively calculate said at least one cardiac parameter based on either the systolic impedance change data or on said data of the velocity of the impedance change.

An optical sensor probe in which one end of optical fibers, of which the other end is connected to a light source or a Doppler measurement device, is linearly supported and arranged in a section of a buckling length L, a movement of the optical fibers in an optical axis direction is restricted at a fiber fixing point on an optical fiber-proximal side in the section of the buckling length L, the optical fibers are protrusively arranged through a restriction hole on an optical fiber-distal side in the section of the buckling length L, and the optical fibers are supported so as to be allowed to move only in the optical axis direction through the restriction hole. A measurement method is capable of measuring a blood flow rate, blood viscosity, or a vascular elastic modulus of the measurement target by measuring a Doppler shift of scattered light from the measurement target due to light emitted from the light source.

Disclosed herein are in vivo non-invasive methods and devices for the measurement of the hemodynamic parameters, such as such as blood pressure, stroke volume, cardiac output, performance of the aortic and mistral heart valves, arterial blood velocity profile, blood viscosity and the blood flow induced arterial wall shear stress, hypertensive/hypotensive and vasodilation/vasocontraction state and aging status of a subject, and the mechanical anelastic in vivo properties of the arterial blood vessels. An exemplary method requires obtaining the peripheral pulse volume waveform (PVW), the peripheral pulse pressure waveform (PPW), and the peripheral pulse velocity waveform (PUW) from the same artery; calculating the time phase shift between the PPW and PVW, and the plot of pulse pressure versus pulse volume; and determining the blood pressures and power law components of the anelastic model from the waveforms PPW and PVW, the cardiac output and heart valves performances from the waveforms PPW and PUW, and the anelastic in vivo properties of the descending, thoracic and abdominal aorta. The disclosed methods and devices can be used to diagnose and treat cardiovascular disease in a subject in need thereof.

A blood inspection system automatically repeats blood inspections at a plurality of times at a desired interval and a desired timing by chronologically coupling a supply of blood to each one of a series of blood inspection units. A change in a blood condition, such as a clotting time, is monitored so that a thrombus or the like is prevented from being formed and an associated medicine is prevented from being overdosed. The blood inspection system has a catheter providing a main flow path, a supply of a flushing liquid, a plurality of inspection units, a plurality of branched flow paths, an aspiration unit, and a switching valve for selectively coupling the main flow path to a determined inspection unit which has not yet performed an inspection.